Not investment advice. Educational platform. See Disclaimer.
NYSE: AVTR
Avantor, Inc.
Healthcare | Medical - Instruments & Supplies
Market prices for AVTR are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (TTM)$-0.81
Avantor, Inc. (NYSE: AVTR) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-20 06:00 UTC.
What Avantor, Inc. does
Avantor is a global provider of products and services to customers in biopharma, healthcare, education, government, and advanced technologies industries. The company operates through two main business segments: a channel distribution business called VWR that sells consumables and equipment to laboratories worldwide, and a specialty product manufacturing business that produces high-purity chemicals, fluid handling systems, and silicone materials.
Summarized from Avantor, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
Revenue, margins & earnings
Net income
Taxes & interest
Operating expenses
Cost of revenue
Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →
2026-09-21Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2026-04-01Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2025-12-18Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
Avantor is a global provider of products and services to customers in biopharma, healthcare, education, government, and advanced technologies industries.
When did AVTR last file with the SEC?
Avantor, Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-12. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 06:00 UTC. This page is also available as JSON at /api/data?ticker=AVTR and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for AVTR and 5,000+ tickers.